Corcept Depression Drug Misses Primary Endpoint

Corcept Therapeutics has reported that a late-stage trial to evaluate its depression drug Corlux failed to reach its main goal but there was a statistically significant correlation between plasma levels and clinical outcome achieved during treatment.
From: www.redorbit.com